Collecting statistically relevant in vivo data on the effects of novel therapies, alone or in combination with other anti-cancer agents, can be a costly and lengthy process. The implantable microdevice (IMD) is a translational tool that allows us to systematically screen many individual and combination therapies in a small cohort of study animals.
Join our webinar to understand how IMDs work, and how we use them to facilitate the collection of robust data for numerous applications, including:
- Combination screening
- Testing of compounds that have no PK or toxicology data
- Candidate comparison
- Specific biology, e.g., candidate interaction with TME
- Clinical translation
Julia Schüler, PhD
Oliver Jonas, PhD
Have a scheduling conflict? Sign up even if you can't make it; we'll share the recording after.
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.